{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:10:22Z","timestamp":1791043822686,"version":"4.1.0"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2012,4,18]],"date-time":"2012-04-18T00:00:00Z","timestamp":1334707200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0035487","type":"journal-article","created":{"date-parts":[[2012,4,18]],"date-time":"2012-04-18T21:05:07Z","timestamp":1334783107000},"page":"e35487","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":49,"title":["Overcoming Multidrug Resistance via Photodestruction of ABCG2-Rich Extracellular Vesicles Sequestering Photosensitive Chemotherapeutics"],"prefix":"10.1371","volume":"7","author":[{"given":"Vicky","family":"Goler-Baron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda G.","family":"Assaraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,4,18]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1146\/annurev.biochem.71.102301.093055","article-title":"Mammalian ABC transporters in health and disease.","volume":"71","author":"P Borst","year":"2002","journal-title":"Annu Rev Biochem"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2174\/1389200043489199","article-title":"The MRP-related and BCRP\/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation.","volume":"5","author":"A Haimeur","year":"2004","journal-title":"Curr Drug Metab"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.febslet.2004.03.123","article-title":"ABCG2 \u2013 a transporter for all seasons.","volume":"567","author":"B Sarkadi","year":"2004","journal-title":"FEBS Lett"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: role of ATP-dependent transporters.","volume":"2","author":"MM Gottesman","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrd1984","article-title":"Targeting multidrug resistance in cancer.","volume":"5","author":"G Szakacs","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10555-007-9049-z","article-title":"Molecular basis of antifolate resistance.","volume":"26","author":"YG Assaraf","year":"2007","journal-title":"Cancer Metastasis Rev"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/bjc.1991.202","article-title":"Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line.","volume":"63","author":"CW Taylor","year":"1991","journal-title":"Br J Cancer"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e16007","DOI":"10.1371\/journal.pone.0016007","article-title":"Structure and Function of ABCG2-Rich Extracellular Vesicles Mediating Multidrug Resistance.","volume":"6","author":"V Goler-Baron","year":"2011","journal-title":"PLoS One"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.bbrc.2008.12.168","article-title":"Riboflavin concentration within ABCG2-rich extracellular vesicles is a novel marker for multidrug resistance in malignant cells.","volume":"380","author":"I Ifergan","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"10952","DOI":"10.1158\/0008-5472.CAN-05-2021","article-title":"Novel extracellular vesicles mediate an ABCG2-dependent anticancer drug sequestration and resistance.","volume":"65","author":"I Ifergan","year":"2005","journal-title":"Cancer Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0026-895X(25)09053-4","article-title":"Inhibition of DNA topoisomerase II by imidazoacridinones, new antineoplastic agents with strong activity against solid tumors.","volume":"49","author":"A Skladanowski","year":"1996","journal-title":"Mol Pharmacol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1124\/mol.109.054791","article-title":"Structural determinants of imidazoacridinones facilitating antitumor activity are crucial for substrate recognition by ABCG2.","volume":"75","author":"EE Bram","year":"2009","journal-title":"Mol Pharmacol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.chembiol.2010.04.012","article-title":"DNA topoisomerases and their poisoning by anticancer and antibacterial drugs.","volume":"17","author":"Y Pommier","year":"2010","journal-title":"Chem Biol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nature05938","article-title":"Antitumour drugs impede DNA uncoiling by topoisomerase I.","volume":"448","author":"DA Koster","year":"2007","journal-title":"Nature"},{"key":"ref15","first-page":"935","article-title":"Circumvention of breast cancer resistance protein (BCRP)-mediated resistance to camptothecins in vitro using non-substrate drugs or the BCRP inhibitor GF120918.","volume":"7","author":"M Maliepaard","year":"2001","journal-title":"Clin Cancer Res"},{"key":"ref16","first-page":"4237","article-title":"The mouse Bcrp1\/Mxr\/Abcp gene: amplification and overexpression in cell lines selected for resistance to topotecan, mitoxantrone, or doxorubicin.","volume":"59","author":"JD Allen","year":"1999","journal-title":"Cancer Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10555-007-9042-6","article-title":"ABCG2: determining its relevance in clinical drug resistance.","volume":"26","author":"RW Robey","year":"2007","journal-title":"Cancer Metastasis Rev"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1751-1097.2009.00585.x","article-title":"Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy.","volume":"85","author":"AE O'Connor","year":"2009","journal-title":"Photochem Photobiol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nrc1071","article-title":"Photodynamic therapy for cancer.","volume":"3","author":"DE Dolmans","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"ref20","article-title":"Imidazoacridinone-dependent lysosomal photodestruction: a pharmacological Trojan horse approach to eradicate multidrug resistant cancers.","author":"Y Adar","year":"2012","journal-title":"Cell Death and Disease, in press"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.bbamem.2007.08.018","article-title":"Crosstalk of tight junction components with signaling pathways.","volume":"1778","author":"L Gonzalez-Mariscal","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.bbamem.2007.07.012","article-title":"Adherens and tight junctions: structure, function and connections to the actin cytoskeleton.","volume":"1778","author":"A Hartsock","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.biocel.2007.02.012","article-title":"Ezrin\/radixin\/moesin: versatile controllers of signaling molecules and of the cortical cytoskeleton.","volume":"40","author":"V Niggli","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/mc.20380","article-title":"TAE226-induced apoptosis in breast cancer cells with overexpressed Src or EGFR.","volume":"47","author":"VM Golubovskaya","year":"2008","journal-title":"Mol Carcinog"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cellbi.2005.11.006","article-title":"Inhibition of MCF-7 breast cancer cell proliferation by MCF-10A breast epithelial cells in coculture.","volume":"30","author":"BC Spink","year":"2006","journal-title":"Cell Biol Int"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1211\/002235703322277177","article-title":"Growth factors and chemotherapeutic modulation of breast cancer cells.","volume":"55","author":"K Ciftci","year":"2003","journal-title":"J Pharm Pharmacol"},{"key":"ref27","first-page":"265","article-title":"ALA UPTAKE AND LASER INDUCED ROS PRODUCTION IN KERATINOCYTES.","volume":"18","author":"IA Radu","year":"2008","journal-title":"Romanian J Biophysics"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1039\/c0pp00147c","article-title":"Targeted photodynamic therapy - a promising strategy of tumor treatment.","volume":"10","author":"AM Bugaj","year":"2011","journal-title":"Photochem Photobiol Sci"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0099-5428(08)60221-X","article-title":"Mitoxantrone Hydrochloride.","volume":"17","author":"JH Beijnen","year":"1988","journal-title":"Analytical Profiles of Drug Substances"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0099-5428(08)60307-X","article-title":"Vincristine Sulfate.","volume":"1","author":"JH Burns","year":"1972","journal-title":"Analytical Profiles of Drug Substances"},{"key":"ref31","first-page":"3052","article-title":"Expression and functional analyses of breast cancer resistance protein in lung cancer.","volume":"9","author":"S Kawabata","year":"2003","journal-title":"Clin Cancer Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/path.1203","article-title":"Frequent expression of the multi-drug resistance-associated protein BCRP\/MXR\/ABCP\/ABCG2 in human tumours detected by the BXP-21 monoclonal antibody in paraffin-embedded material.","volume":"198","author":"JE Diestra","year":"2002","journal-title":"J Pathol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1084\/jem.187.10.1583","article-title":"Defective acidification in human breast tumor cells and implications for chemotherapy.","volume":"187","author":"N Altan","year":"1998","journal-title":"J Exp Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1021\/bi952234e","article-title":"Defective pH regulation of acidic compartments in human breast cancer cells (MCF-7) is normalized in adriamycin-resistant cells (MCF-7adr).","volume":"35","author":"M Schindler","year":"1996","journal-title":"Biochemistry"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0163-7258(99)00073-X","article-title":"Resistance mechanisms associated with altered intracellular distribution of anticancer agents.","volume":"85","author":"AK Larsen","year":"2000","journal-title":"Pharmacol Ther"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0035487","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:12:05Z","timestamp":1742947925000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0035487"}},"subtitle":[],"editor":[{"given":"Irina V.","family":"Lebedeva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,4,18]]},"references-count":35,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012,4,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0035487","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,18]]}}}